Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03462823

Use of an Osteoconductive Scaffold in ACL-Reconstruction

Randomized Controlled Trial for the Use of an Osteoconductive Scaffold in ACL-Reconstruction

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
56 (estimated)
Sponsor
Sandro Fucentese · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Primary objective of the study is to evaluate efficacy of the surgical technique for ACL reconstruction using an osteoconductive scaffold, enlaced into the hamstring tendon autograft, compared to the traditional technique.

Detailed description

Reconstruction of the anterior cruciate ligament (ACL) using autograft tissue is currently recommended as the standard of care following an ACL tear or rupture, with the bone-tendon-bone (BTB) graft and hamstring tendon graft the most common. Although a BTB autograft is widely recognized to offer high mechanical performance and rapid graft healing, these advantages come at the cost of a longer surgery time and higher risk of severe patient discomfort at the graft harvest site. Use of a hamstring tendon autograft is less painful, but is generally slower to heal with higher risk of mechanical graft failure due to poor bone ingrowth. The aim of the current study is to augment graft-to-bone incorporation by use of an osteoconductive scaffold enlaced into the hamstring tendon autograft. This bovine derived composite bone substitute is inserted into the articular aperture of the femoral bone tunnel and should provide an osteoconductive / osteoinductive environment at a biomimetic attachment site leading to improved secondary graft-fixation and a reduced incidence of tunnel widening. Primary objective of the study is to evaluate efficacy of the surgical technique for ACL reconstruction using an osteoconductive scaffold, enlaced into the hamstring tendon autograft, compared to the traditional technique. Secondary objectives aim to assess the clinical outcome of the interventional treatment including patient subjective knee function and objective measures of knee stability.

Conditions

Interventions

TypeNameDescription
DEVICEOsteoconductive scaffold-hamstring tendon composite repairThe device under study is a composite bone substitute composed of a natural mineral matrix of bovine origin, reinforced with biodegradable synthetic polymers and natural collagen derivatives of bovine origin (smartbone, IBI S.A., Switzerland).
DEVICEHamstring tendon-only repairACL-reconstruction using hamstring autograft with hybrid fixation in accordance with in-house standard of care.

Timeline

Start date
2017-04-29
Primary completion
2024-01-29
Completion
2025-12-29
First posted
2018-03-13
Last updated
2024-08-06

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03462823. Inclusion in this directory is not an endorsement.